BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barr ELM, Barzi F, Hughes JT, Jerums G, Hoy WE, O'Dea K, Jones GRD, Lawton PD, Brown ADH, Thomas M, Ekinci EI, Sinha A, Cass A, MacIsaac RJ, Maple-Brown LJ. High Baseline Levels of Tumor Necrosis Factor Receptor 1 Are Associated With Progression of Kidney Disease in Indigenous Australians With Diabetes: The eGFR Follow-up Study. Diabetes Care 2018;41:739-47. [PMID: 29367427 DOI: 10.2337/dc17-1919] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Vanholder R, Glorieux G. Uremic Toxicity. Handbook of Dialysis Therapy 2023. [DOI: 10.1016/b978-0-323-79135-9.00002-1] [Reference Citation Analysis]
2 Hofherr A, Williams J, Gan LM, Söderberg M, Hansen PBL, Woollard KJ. Targeting inflammation for the treatment of Diabetic Kidney Disease: a five-compartment mechanistic model. BMC Nephrol 2022;23:208. [PMID: 35698028 DOI: 10.1186/s12882-022-02794-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wu TH, Chang LH, Chu CH, Hwu CM, Chen HS, Lin LY. Soluble tumor necrosis factor receptor 2 is associated with progressive diabetic kidney disease in patients with type 2 diabetes mellitus. PLoS One 2022;17:e0266854. [PMID: 35413081 DOI: 10.1371/journal.pone.0266854] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lousa I, Reis F, Santos-Silva A, Belo L. The Signaling Pathway of TNF Receptors: Linking Animal Models of Renal Disease to Human CKD. Int J Mol Sci 2022;23:3284. [PMID: 35328704 DOI: 10.3390/ijms23063284] [Reference Citation Analysis]
5 Murkamilov IT. The bi-directional effect of markers of inflammation and a decrease in glomerular filtration rate in chronic kidney disease. Klin Lab Diagn 2022;67:37-42. [PMID: 35077068 DOI: 10.51620/0869-2084-2022-67-1-37-42] [Reference Citation Analysis]
6 Barutta F, Bellini S, Canepa S, Durazzo M, Gruden G. Novel biomarkers of diabetic kidney disease: current status and potential clinical application. Acta Diabetol 2021;58:819-30. [PMID: 33528734 DOI: 10.1007/s00592-020-01656-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
7 Verwijmeren L, Bosma M, Vernooij LM, Linde EM, Dijkstra IM, Daeter EJ, Van Dongen EPA, Van Klei WA, Noordzij PG. Associations Between Preoperative Biomarkers and Cardiac Surgery-Associated Acute Kidney Injury in Elderly Patients: A Cohort Study. Anesth Analg 2021. [PMID: 34153017 DOI: 10.1213/ANE.0000000000005650] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Knudsen L, Lyons JG, O'Dea K, Christensen DL, Brimblecombe JK. Antioxidant biomarkers and cardiometabolic risk markers in an Aboriginal community in remote Australia: a cross-sectional study. Public Health Nutr 2021;24:4937-48. [PMID: 33261694 DOI: 10.1017/S1368980020004899] [Reference Citation Analysis]
9 Majoni SW, Barzi F, Hoy W, MacIsaac RJ, Cass A, Maple-Brown L, Hughes JT. Baseline liver function tests and full blood count indices and their association with progression of chronic kidney disease and renal outcomes in Aboriginal and Torres Strait Islander people: the eGFR follow- up study. BMC Nephrol 2020;21:523. [PMID: 33261565 DOI: 10.1186/s12882-020-02185-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Maalmi H, Herder C, Strassburger K, Urner S, Jandeleit-Dahm K, Zaharia OP, Karusheva Y, Bongaerts BWC, Rathmann W, Burkart V, Szendroedi J, Roden M. Biomarkers of Inflammation and Glomerular Filtration Rate in Individuals with Recent-Onset Type 1 and Type 2 Diabetes. J Clin Endocrinol Metab 2020;105:dgaa622. [PMID: 32879938 DOI: 10.1210/clinem/dgaa622] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Kurth MJ, McBride WT, McLean G, Watt J, Domanska A, Lamont JV, Maguire D, Fitzgerald P, Ruddock MW. Acute kidney injury risk in orthopaedic trauma patients pre and post surgery using a biomarker algorithm and clinical risk score. Sci Rep 2020;10:20005. [PMID: 33203963 DOI: 10.1038/s41598-020-76929-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
12 Majoni SW, Lawton PD, Rathnayake G, Barzi F, Hughes JT, Cass A. Narrative Review of Hyperferritinemia, Iron Deficiency, and the Challenges of Managing Anemia in Aboriginal and Torres Strait Islander Australians With CKD. Kidney Int Rep 2021;6:501-12. [PMID: 33615076 DOI: 10.1016/j.ekir.2020.10.035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Mitrofanova A, Fontanella AM, Merscher S, Fornoni A. Lipid deposition and metaflammation in diabetic kidney disease. Curr Opin Pharmacol. 2020;55:60-72. [PMID: 33137677 DOI: 10.1016/j.coph.2020.09.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
14 Liu L, Gao B, Wang J, Yang C, Wu S, Wu Y, Chen S, Li Q, Zhang H, Wang G, Chen M, Zhao MH, Zhang L. Clinical significance of single and persistent elevation of serum high-sensitivity C-reactive protein levels for prediction of kidney outcomes in patients with impaired fasting glucose or diabetes mellitus. J Nephrol 2021;34:1179-88. [PMID: 32880885 DOI: 10.1007/s40620-020-00848-4] [Reference Citation Analysis]
15 Ihara K, Skupien J, Krolewski B, Md Dom ZI, O'Neil K, Satake E, Kobayashi H, Rashidi NM, Niewczas MA, Krolewski AS. A profile of multiple circulating tumor necrosis factor receptors associated with early progressive kidney decline in Type 1 Diabetes is similar to profiles in autoimmune disorders. Kidney Int 2021;99:725-36. [PMID: 32717193 DOI: 10.1016/j.kint.2020.07.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
16 Murakoshi M, Gohda T, Suzuki Y. Circulating Tumor Necrosis Factor Receptors: A Potential Biomarker for the Progression of Diabetic Kidney Disease. Int J Mol Sci 2020;21:E1957. [PMID: 32183005 DOI: 10.3390/ijms21061957] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
17 Barr ELM, Barzi F, Rohit A, Cunningham J, Tatipata S, McDermott R, Hoy WE, Wang Z, Bradshaw PJ, Dimer L, Thompson PL, Brimblecombe J, O'Dea K, Connors C, Burgess P, Guthridge S, Brown A, Cass A, Shaw JE, Maple-Brown L. Performance of cardiovascular risk prediction equations in Indigenous Australians. Heart 2020;106:1252-60. [PMID: 31949024 DOI: 10.1136/heartjnl-2019-315889] [Reference Citation Analysis]
18 Cheng D, Fei Y, Saulnier P, Wang N. Circulating TNF receptors and risk of renal disease progression, cardiovascular disease events and mortality in patients with diabetes: a systematic review and meta-analysis. Endocrine 2020;68:32-43. [DOI: 10.1007/s12020-019-02153-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 McBride WT, Kurth MJ, McLean G, Domanska A, Lamont JV, Maguire D, Watt J, Fitzgerald P, Young I, Joseph J, Ruddock MW. Stratifying risk of acute kidney injury in pre and post cardiac surgery patients using a novel biomarker-based algorithm and clinical risk score. Sci Rep 2019;9:16963. [PMID: 31740699 DOI: 10.1038/s41598-019-53349-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
20 Xiang AS, Ekinci EI, MacIsaac RJ. Inflammatory proteins in diabetic kidney disease-potential as biomarkers and therapeutic targets. Ann Transl Med 2019;7:S243. [PMID: 31656822 DOI: 10.21037/atm.2019.08.20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Ye X, Luo T, Wang K, Wang Y, Yang S, Li Q, Hu J. Circulating TNF receptors 1 and 2 predict progression of diabetic kidney disease: A meta-analysis. Diabetes Metab Res Rev 2019;35:e3195. [PMID: 31207020 DOI: 10.1002/dmrr.3195] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
22 Niewczas MA, Pavkov ME, Skupien J, Smiles A, Md Dom ZI, Wilson JM, Park J, Nair V, Schlafly A, Saulnier PJ, Satake E, Simeone CA, Shah H, Qiu C, Looker HC, Fiorina P, Ware CF, Sun JK, Doria A, Kretzler M, Susztak K, Duffin KL, Nelson RG, Krolewski AS. A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes. Nat Med 2019;25:805-13. [PMID: 31011203 DOI: 10.1038/s41591-019-0415-5] [Cited by in Crossref: 172] [Cited by in F6Publishing: 177] [Article Influence: 57.3] [Reference Citation Analysis]
23 MacIsaac RJ, Farag M, Obeyesekere V, Clarke M, Boston R, Ward GM, Jerums G, Ekinci EI. Changes in soluble tumor necrosis factor receptor type 1 levels and early renal function decline in patients with diabetes. J Diabetes Investig 2019;10:1537-42. [PMID: 30989829 DOI: 10.1111/jdi.13061] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
24 Zou LX, Sun L. Global diabetic kidney disease research from 2000 to 2017: A bibliometric analysis. Medicine (Baltimore) 2019;98:e14394. [PMID: 30732183 DOI: 10.1097/MD.0000000000014394] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]